(19)
(11) EP 1 364 038 A2

(12)

(88) Date of publication A3:
04.09.2003

(43) Date of publication:
26.11.2003 Bulletin 2003/48

(21) Application number: 01962700.9

(22) Date of filing: 01.06.2001
(51) International Patent Classification (IPC)7C12N 15/86, C12N 15/34, C12N 5/10, C07K 14/075, C12N 7/04
(86) International application number:
PCT/EP0106/286
(87) International publication number:
WO 0109/2299 (06.12.2001 Gazette 2001/49)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 02.06.2000 US 585344
22.02.2001 US 270555 P

(71) Applicants:
  • Novartis AG
    4056 Basel (CH)

    BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE 
  • Novartis Pharma GmbH
    1230 Wien (AT)

    AT 

(72) Inventors:
  • JAKUBCZAK, John, Leonard
    Germantown, MD 20874 (US)
  • ROLLENCE, Michele, Lynette
    Damascus, MD 20872 (US)
  • STEWART, David, A.
    Eldersburg, MD 21784 (US)
  • STEVENSON, Susan, C.
    Frederick, MD 21701 (US)
  • HALLENBECK, Paul, L.
    Gaithersburg, MD 20882 (US)
  • IDAMKANTI, Neeaja
    Gaithersburg, MD 20878 (US)
  • KALEKO, Michael
    Rockville, MD 20854 (US)
  • SMITH, Theodore
    Ijamsville, MD 21754 (US)

(74) Representative: Gros, Florent 
Novartis AG
4002 Basel
4002 Basel (CH)

   


(54) ADENOVIRUS PARTICLES WITH MUTAGENIZED FIBER PROTEINS